Beebread, Clovone, Cow Clover, Daidzein, Genistein, Isoflavone, Meadow Clover, Miel des Prés, Phytoestrogen, Purple Clover, Trebol Rojo, Trèfle Commun, Trèfle des Prés, Trèfle Pourpre, Trèfle Rouge, Trèfle Rougeâtre, Trèfle Violet, Trefoil, Trifolium, Trifolium pratense, Wild Clover.
Red clover is a plant. The flower tops are used to make medicine.
Red clover is used for many conditions, but so far, there isn't enough scientific evidence to determine whether it is effective for any of them. It doesn't seem to work, though, for lowering cholesterol or controlling hot flashes in women.
Red clover is used for cancer prevention, weak bones (osteoporosis), indigestion, high cholesterol, whooping cough, cough, asthma, bronchitis, and sexually transmitted diseases (STDs).
Some women use red clover for symptoms of menopause such as hot flashes; for breast pain or tenderness (mastalgia); and for premenstrual syndrome (PMS).
Red clover is applied to the skin for skin cancer, skin sores, burns, and chronic skin diseases including eczema and psoriasis.
In foods and beverages, the solid extract of red clover is used as a flavoring ingredient.
Red clover contains hormone-like chemicals called isoflavones that seem to cause reproductive problems in certain animals. Experts think a diet high in isoflavones may have been responsible for reports of reproductive failure and liver disease in cheetahs living in zoos. In large quantities, red clover can cause sterility in livestock.
How does it work?
Red clover contains "isoflavones" which are changed in the body to "phytoestrogens" that are similar to the hormone estrogen.
QUESTION
Next to red peppers, you can get the most vitamin C from ________________. See AnswerPossibly Ineffective for...
- Weak bones (osteoporosis). Some early research suggests that taking red clover daily for 6 months increased bone mineral density and healthy postmenopausal women. However, most evidence suggests that taking red clover does not improve osteoporosis.
Insufficient Evidence to Rate Effectiveness for...
- Hair loss (alopecia). Early research shows that applying a combination product containing red clover flower extract might increase hair growth in people with hair loss.
- Enlarged prostate gland (benign prostatic hyperplasia). Some early research suggests that red clover supplements might improve some symptoms of an enlarged prostate. It seems to reduce nighttime urination.
- Breast cancer. Early evidence shows that taking a specific red clover extract (Promensil) daily for one year does not increase breast tissue density, suggesting that it might not affect breast cancer risk.
- Cancer of the lining of the uterus (endometrial cancer). Early research suggests that taking red clover supplements does not help prevent endometrial cancer.
- High cholesterol. Most research shows that taking red clover extracts by mouth for 3 months to a year does not seem reduce low-density lipoprotein (LDL or "bad") cholesterol or increase high-density lipoprotein (HDL or "good") cholesterol in women who have moderately elevated cholesterol levels.
- Breast pain (mastalgia). There is some early evidence that red clover might help relieve cyclic breast pain and tenderness.
- Menopause symptoms. There are contradictory research findings about the effects of red clover on symptoms of menopause. Most research shows that taking red clover by mouth for up to a year does not reduce menopause symptoms such as hot flashes, although some research shows that a specific red clover product (Promensil, Novogen) might reduce severity, but not the frequency of hot flashes. Other research shows that a some forms of red clover might improve symptoms of menopause-related anxiety and depression. Overall, there is conflicting evidence with regard to its efficacy in symptoms of menopause, including sleep habits, night sweats, and improving anxiety.
- Indigestion.
- Lung problems (cough, bronchitis, asthma).
- Premenstrual syndrome (PMS).
- Sexually transmitted diseases (STDs).
- Skin problems (cancerous growths, burns, eczema, psoriasis).
- Other conditions.
Natural Medicines Comprehensive Database rates effectiveness based on scientific evidence according to the following scale: Effective, Likely Effective, Possibly Effective, Possibly Ineffective, Likely Ineffective, and Insufficient Evidence to Rate (detailed description of each of the ratings).
Red clover is LIKELY SAFE for most people when used in the amounts found in food. It is POSSIBLY SAFE when used in medicinal amounts by mouth or applied to the skin.
Red clover can cause rash-like reactions, muscle ache, headache, nausea, and vaginal bleeding (spotting) in some women.
SLIDESHOW
Vitamin D Deficiency: How Much Vitamin D Is Enough? See SlideshowNot enough is known about the safety of red clover when applied to the skin during pregnancy or breast-feeding. Stay on the safe side and don't use it.
Bleeding disorders: Red clover might increase the chance of bleeding. Avoid large amounts and use with caution.
Hormone-sensitive conditions such as breast cancer, uterine cancer, ovarian cancer, endometriosis, or uterine fibroids: Red clover might act like estrogen. If you have any condition that might be made worse by exposure to estrogen, don't use red clover.
Protein S deficiency: People with protein S deficiency have an increased risk of forming blood clots. There is some concern that red clover might increase the risk of clot formation in these people because it has some of the effects of estrogen. Don't use red clover if you have protein S deficiency.
Surgery: Red clover might slow blood clotting. It might increase the chance of extra bleeding during and after surgery. Stop taking red clover at least 2 weeks before a scheduled surgery.
There isn't enough information to rate the safety of red clover when applied to the skin.
Birth control pills (Contraceptive drugs)Interaction Rating: Moderate Be cautious with this combination.Talk with your health provider.
Some birth control pills contain estrogen. Red clover might have some of the same effects as estrogen. However, red clover isn't as strong as the estrogen in birth control pills. Taking red clover along with birth control pills might decrease the effectiveness of birth control pills. If you take birth control pills along with red clover, use an additional form of birth control such as a condom.
Some birth control pills include ethinyl estradiol and levonorgestrel (Triphasil), ethinyl estradiol and norethindrone (Ortho-Novum 1/35, Ortho-Novum 7/7/7), and others.
EstrogensInteraction Rating: Moderate Be cautious with this combination.Talk with your health provider.
Large amounts of red clover might have some of the same effects as estrogen. However, red clover isn't as strong as estrogen pills. Taking red clover along with estrogen pills might decrease the effects of estrogen pills.
Some estrogen pills include conjugated equine estrogens (Premarin), ethinyl estradiol, estradiol, and others.
Medications changed by the liver (Cytochrome P450 1A2 (CYP1A2) substrates)Interaction Rating: Moderate Be cautious with this combination.Talk with your health provider.
Some medications are changed and broken down by the liver. Red clover might decrease how quickly the liver breaks down some medications. Taking red clover along with some medications that are broken down by the liver can increase the effects and side effects of these medications. Before taking red clover, talk to your healthcare provider if you take any medications that are changed by the liver.
Some medications that are changed by the liver include amitriptyline (Elavil), haloperidol (Haldol), ondansetron (Zofran), propranolol (Inderal), theophylline (Theo-Dur, others), verapamil (Calan, Isoptin, others), and others.
Medications changed by the liver (Cytochrome P450 2C19 (CYP2C19) substrates)Interaction Rating: Moderate Be cautious with this combination.Talk with your health provider.
Some medications are changed and broken down by the liver. Red clover might decrease how quickly the liver breaks down some medications. Taking red clover along with some medications that are broken down by the liver can increase the effects and side effects of these medications. Before taking red clover, talk to your healthcare provider if you take any medications that are changed by the liver.
Some medications that are changed by the liver include omeprazole (Prilosec), lansoprazole (Prevacid), and pantoprazole (Protonix); diazepam (Valium); carisoprodol (Soma); nelfinavir (Viracept); and others.
Medications changed by the liver (Cytochrome P450 2C9 (CYP2C9) substrates)Interaction Rating: Moderate Be cautious with this combination.Talk with your health provider.
Some medications are changed and broken down by the liver. Red clover might decrease how quickly the liver breaks down some medications. Taking red clover along with some medications that are broken down by the liver can increase the effects and side effects of these medications. Before taking red clover, talk to your healthcare provider if you take any medications that are changed by the liver.
Some medications that are changed by the liver include diclofenac (Cataflam, Voltaren), ibuprofen (Motrin), meloxicam (Mobic), and piroxicam (Feldene); celecoxib (Celebrex); amitriptyline (Elavil); warfarin (Coumadin); glipizide (Glucotrol); losartan (Cozaar); and others.
Medications changed by the liver (Cytochrome P450 3A4 (CYP3A4) substrates)Interaction Rating: Moderate Be cautious with this combination.Talk with your health provider.
Some medications are changed and broken down by the liver. Red clover might decrease how quickly the liver breaks down some medications. Taking red clover along with some medications that are broken down by the liver can increase the effects and side effects of these medications. Before taking red clover, talk to your healthcare provider if you are taking any medications that are changed by the liver.
Some medications changed by the liver include lovastatin (Mevacor), ketoconazole (Nizoral), itraconazole (Sporanox), fexofenadine (Allegra), triazolam (Halcion), and many others.
Medications that slow blood clotting (Anticoagulant / Antiplatelet drugs)Interaction Rating: Moderate Be cautious with this combination.Talk with your health provider.
Large amounts of red clover might slow blood clotting. Taking red clover along with medications that also slow clotting might increase the chances of bruising and bleeding.
Some medications that slow blood clotting include aspirin, clopidogrel (Plavix), diclofenac (Voltaren, Cataflam, others), ibuprofen (Advil, Motrin, others), naproxen (Anaprox, Naprosyn, others), dalteparin (Fragmin), enoxaparin (Lovenox), heparin, warfarin (Coumadin), and others.
Tamoxifen (Nolvadex)Interaction Rating: Moderate Be cautious with this combination.Talk with your health provider.
Some types of cancer are affected by hormones in the body. Estrogen-sensitive cancers are cancers that are affected by estrogen levels in the body. Tamoxifen (Nolvadex) is used to help treat and prevent these types of cancer. Red clover seems to also affect estrogen levels in the body. By affecting estrogen in the body, red clover might decrease the effectiveness of tamoxifen (Nolvadex). Do not take red clover if you are taking tamoxifen (Nolvadex).
The appropriate dose of red clover depends on several factors such as the user's age, health, and several other conditions. At this time there is not enough scientific information to determine an appropriate range of doses for red clover. Keep in mind that natural products are not always necessarily safe and dosages can be important. Be sure to follow relevant directions on product labels and consult your pharmacist or physician or other healthcare professional before using.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Abernethy K, Brockie J, Suffling K, and et al. An open study of the effects of a 40mg isoflavone food supplement (derived from Red Clover), on menopausal symptoms. The British Menopause Society (2001). 2001;
Atkinson C, Compston JE, Robins SP, and et al. The effects of isoflavone phytoestrogens on bone: preliminary results from a large randomized controlled trial. Endocr Soc Annu Meet Program 2000;82:196.
Atkinson C, Warren RM, Dowsett M, and et al. Effects of isoflavones on breast density, oestradiol, and gonadotrophins: A double blind randomised placebo controlled trial. Poster presented at: The Endocrine Society's 83rd Annual Meeting (2000).
Baber R, Clifton Bligh P, Fulcher G, and et al. The effect of an isoflavone extract (PO81) on serum lipids, forearm bone density and endometrial thickness in postmenopausal women [Abstract]. Proceedings of the North American Menopause Society (New York, 1999).
Barnes, S. Effect of genistein on in vitro and in vivo models of cancer. J Nutr 1995;125(3 Suppl):777S-783S. View abstract.
Blakesmith, S. J., Lyons-Wall, P. M., Joannou, G. E., Petocz, P., and Samman, S. Urinary isoflavonoid excretion is inversely associated with the ratio of protein to dietary fibre intake in young women. Eur.J Clin Nutr 2005;59(2):284-290. View abstract.
Burdette, J. E., Liu, J., Lantvit, D., Lim, E., Booth, N., Bhat, K. P., Hedayat, S., van Breemen, R. B., Constantinou, A. I., Pezzuto, J. M., Farnsworth, N. R., and Bolton, J. L. Trifolium pratense (red clover) exhibits estrogenic effects in vivo in ovariectomized Sprague-Dawley rats. J Nutr 2002;132(1):27-30. View abstract.
Chan, H. Y., Wang, H., and Leung, L. K. The red clover (Trifolium pratense) isoflavone biochanin A modulates the biotransformation pathways of 7,12-dimethylbenz[a]anthracene. Br J Nutr 2003;90(1):87-92. View abstract.
Domon, O. E., McGarrity, L. J., Bishop, M., Yoshioka, M., Chen, J. J., and Morris, S. M. Evaluation of the genotoxicity of the phytoestrogen, coumestrol, in AHH- 1 TK(+/-) human lymphoblastoid cells. Mutat.Res 3-1-2001;474(1-2):129-137. View abstract.
Finking, G., Wohlfrom, M., Lenz, C., Wolkenhauer, M., Eberle, C., and Hanke, H. The phytoestrogens Genistein and Daidzein, and 17 beta-estradiol inhibit development of neointima in aortas from male and female rabbits in vitro after injury. Coron.Artery Dis. 1999;10(8):607-615. View abstract.
Friedman, J. A., Taylor, S. A., McDermott, W., and Alikhani, P. Multifocal and recurrent subarachnoid hemorrhage due to an herbal supplement containing natural coumarins. Neurocrit.Care 2007;7(1):76-80. View abstract.
Gerber G, Lowe FC, and Spigelman S. The use of a standardized extract of red clover isoflavones for the alleviation of BPH symptoms. The Endocrine Society's 82nd Annual Meeting 2000;82:2359.
Hamilton-Reeves, J. M., Vazquez, G., Duval, S. J., Phipps, W. R., Kurzer, M. S., and Messina, M. J. Clinical studies show no effects of soy protein or isoflavones on reproductive hormones in men: results of a meta-analysis. Fertil.Steril. 2010;94(3):997-1007. View abstract.
Hooper, L., Madhavan, G., Tice, J. A., Leinster, S. J., and Cassidy, A. Effects of isoflavones on breast density in pre- and post-menopausal women: a systematic review and meta-analysis of randomized controlled trials. Hum.Reprod.Update. 2010;16(6):745-760. View abstract.
Jarred, R. A., Keikha, M., Dowling, C., McPherson, S. J., Clare, A. M., Husband, A. J., Pedersen, J. S., Frydenberg, M., and Risbridger, G. P. Induction of apoptosis in low to moderate-grade human prostate carcinoma by red clover-derived dietary isoflavones. Cancer Epidemiol.Biomarkers Prev. 2002;11(12):1689-1696. View abstract.
Jeri AR. The effect of isoflavone phytoestrogens in relieving hot flushes in Peruvian post menopausal women. 9th International Menopause Society World Congress on the Menopause (1999).
Jeri, A. R. The use of an isoflavone supplement to relieve hot flushes. Female Patient 2002;27:35-37.
Kelley, K. W. and Carroll, D. G. Evaluating the evidence for over-the-counter alternatives for relief of hot flashes in menopausal women. J.Am.Pharm.Assoc.(2003.) 2010;50(5):e106-e115. View abstract.
Knight DC. The effect of Promensil, an isoflavone extract, on menopausal symptoms . Climacteric 1999;2:79-84.
Knight, D. C. and Eden, J. A. A review of the clinical effects of phytoestrogens. Obstet.Gynecol. 1996;87(5 Pt 2):897-904. View abstract.
Kolodziejczyk-Czepas, J. Trifolium species-derived substances and extracts--biological activity and prospects for medicinal applications. J.Ethnopharmacol. 8-30-2012;143(1):14-23. View abstract.
Leach, M. J. and Moore, V. Black cohosh (Cimicifuga spp.) for menopausal symptoms. Cochrane.Database.Syst.Rev. 2012;9:CD007244. View abstract.
Lee, C. C., Bloem, C. J., Kasa-Vubu, J. Z., and Liang, L. J. Effect of oral phytoestrogen on androgenicity and insulin sensitivity in postmenopausal women. Diabetes Obes.Metab 2012;14(4):315-319. View abstract.
Lipovac, M., Chedraui, P., Gruenhut, C., Gocan, A., Kurz, C., Neuber, B., and Imhof, M. The effect of red clover isoflavone supplementation over vasomotor and menopausal symptoms in postmenopausal women. Gynecol.Endocrinol. 2012;28(3):203-207. View abstract.
Lovati, M. R., Manzoni, C., Canavesi, A., Sirtori, M., Vaccarino, V., Marchi, M., Gaddi, G., and Sirtori, C. R. Soybean protein diet increases low density lipoprotein receptor activity in mononuclear cells from hypercholesterolemic patients. J Clin Invest 1987;80(5):1498-1502. View abstract.
Ma, H., Sullivan-Halley, J., Smith, A. W., Neuhouser, M. L., Alfano, C. M., Meeske, K., George, S. M., McTiernan, A., McKean-Cowdin, R., Baumgartner, K. B., Ballard-Barbash, R., and Bernstein, L. Estrogenic botanical supplements, health-related quality of life, fatigue, and hormone-related symptoms in breast cancer survivors: a HEAL study report. BMC.Complement Altern.Med. 2011;11:109. View abstract.
Medjakovic, S. and Jungbauer, A. Red clover isoflavones biochanin A and formononetin are potent ligands of the human aryl hydrocarbon receptor. J.Steroid Biochem.Mol.Biol. 2008;108(1-2):171-177. View abstract.
Nachtigall LB, La Grega L, Lee WW, and et al. The effects of isoflavones derived from red clover on vasomotor symptoms and endometrial thickness. 9th International Menopause Society World Congress on the Menopause. 1999;331-336.
Nissan, H. P., Lu, J., Booth, N. L., Yamamura, H. I., Farnsworth, N. R., and Wang, Z. J. A red clover (Trifolium pratense) phase II clinical extract possesses opiate activity. J Ethnopharmacol 5-30-2007;112(1):207-210. View abstract.
Peterson, G. and Barnes, S. Genistein and biochanin A inhibit the growth of human prostate cancer cells but not epidermal growth factor receptor tyrosine autophosphorylation. Prostate 1993;22(4):335-345. View abstract.
Peterson, G. and Barnes, S. Genistein inhibition of the growth of human breast cancer cells: independence from estrogen receptors and the multi-drug resistance gene. Biochem.Biophys.Res.Commun. 8-30-1991;179(1):661-667. View abstract.
Pitkin, J. Alternative and complementary therapies for the menopause. Menopause.Int. 2012;18(1):20-27. View abstract.
Reiter, E., Beck, V., Medjakovic, S., Mueller, M., and Jungbauer, A. Comparison of hormonal activity of isoflavone-containing supplements used to treat menopausal complaints. Menopause. 2009;16(5):1049-1060. View abstract.
Rosenberg Zand, R. S., Jenkins, D. J., and Diamandis, E. P. Effects of natural products and nutraceuticals on steroid hormone-regulated gene expression. Clin Chim.Acta 2001;312(1-2):213-219. View abstract.
Samman, S., Koh, H. S., Flood, V. M., Blakesmith, S. J., Petocz, P., and Lyons-Wall, P. M. Red clover (Trifolium pratense) isoflavones and serum homocysteine in premenopausal women: a pilot study. J.Womens Health (Larchmt.) 2009;18(11):1813-1816. View abstract.
Shulman, L. P., Banuvar, S., Fong, H. H., and Farnsworth, N. R. Discussion of a well-designed clinical trial which did not demonstrate effectiveness: UIC center for botanical dietary supplements research study of black cohosh and red clover. Fitoterapia 2011;82(1):88-91. View abstract.
Stephens, F. O. Phytoestrogens and prostate cancer: possible preventive role. Med J Aust. 8-4-1997;167(3):138-140. View abstract.
Suh, K. S., Koh, G., Park, C. Y., Woo, J. T., Kim, S. W., Kim, J. W., Park, I. K., and Kim, Y. S. Soybean isoflavones inhibit tumor necrosis factor-alpha-induced apoptosis and the production of interleukin-6 and prostaglandin E2 in osteoblastic cells. Phytochemistry 2003;63(2):209-215. View abstract.
Tice J, Cummings SR Ettinger B et al. Few adverse effects of two red clover extracts rich in phytoestrogens: a multicenter, placebo-controlled trial. Alt Ther 2001;7:S33.
Tomar, R. S. and Shiao, R. Early life and adult exposure to isoflavones and breast cancer risk. J.Environ.Sci.Health C.Environ.Carcinog.Ecotoxicol.Rev. 2008;26(2):113-173. View abstract.
Umland, E. M. Treatment strategies for reducing the burden of menopause-associated vasomotor symptoms. J.Manag.Care Pharm. 2008;14(3 Suppl):14-19. View abstract.
Vrieling, A., Rookus, M. A., Kampman, E., Bonfrer, J. M., Bosma, A., Cats, A., van, Doorn J., Korse, C. M., Witteman, B. J., van Leeuwen, F. E., van't Veer, L. J., and Voskuil, D. W. No effect of red clover-derived isoflavone intervention on the insulin-like growth factor system in women at increased risk of colorectal cancer. Cancer Epidemiol.Biomarkers Prev. 2008;17(10):2585-2593. View abstract.
Vrieling, A., Rookus, M. A., Kampman, E., Bonfrer, J. M., Korse, C. M., van Doorn, J., Lampe, J. W., Cats, A., Witteman, B. J., van Leeuwen, F. E., van't Veer, L. J., and Voskuil, D. W. Isolated isoflavones do not affect the circulating insulin-like growth factor system in men at increased colorectal cancer risk. J Nutr 2007;137(2):379-383. View abstract.
Wang, Y., Man, Gho W., Chan, F. L., Chen, S., and Leung, L. K. The red clover (Trifolium pratense) isoflavone biochanin A inhibits aromatase activity and expression. Br.J Nutr 2008;99(2):303-310. View abstract.
Anderson JW, Johnstone BM, Cook-Newell ME. Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med 1995;333:276-82. View abstract.
Anon. The role of isoflavones in menopausal health: consensus opinion of the North American Menopause Society. Menopause 2000;7:215-29.. View abstract.
Anthony MS. Soy and cardiovascular disease: Cholesterol lowering and beyond. J Nutr 2000;130:662S-3S. View abstract.
Atkinson C, Compston JE, Day NE, et al. The effects of phytoestrogen isoflavones on bone density in women: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr 2004;79:326-33. View abstract.
Atkinson C, Oosthuizen W, Scollen S, et al. Modest protective effects of isoflavones from a red clover-derived dietary supplement on cardiovascular disease risk factors in perimenopausal women, and evidence of an interaction with ApoE genotype in 49-65 year-old women. J Nutr 2004;134:1759-64. View abstract.
Atkinson C, Warren RM, Sala E, et al. Red clover-derived isoflavones and mammographic breast density: a double-blind, randomized, placebo-controlled trial [ISRCTN42940165]. Breast Cancer Res 2004;6:R170-R179. View abstract.
Baber R, Clifton Bligh P, Fulcher G, et al. The effect of an isoflavone extract (PO81) on serum lipids, forearm bone density and endometrial thickness in postmenopausal women [Abstract]. Proceedings of the North American Menopause Society (New York, 1999).
Baber RJ, Templeman C, Morton T, et al. Randomized placebo-controlled trial of an isoflavone supplement and menopausal symptoms in women. Climacteric 1999;2:85-92.. View abstract.
Baird DD, Umbach DM, Lansdell L, et al. Dietary intervention study to assess estrogenicity of dietary soy among postmenopausal women. J Clin Endocrinol Metab 1995;80:1685-90. View abstract.
Barnes S, Kim H, Darley-Usmar V, et al. Beyond ERalpha and ERbeta: Estrogen receptor binding is only part of the isoflavone story. J Nutr 2000;130:656S-7S. View abstract.
Blakesmith SJ, Lyons-Wall PM, George C, et al. Effects of supplementation with purified red clover (Trifolium pratense) isoflavones on plasma lipids and insulin resistance in healthy premenopausal women. Br J Nutr 2003;89(4):467-474. View abstract.
Budzinski JW, Foster BC, Vandenhoek S, Arnason JT. An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures. Phytomedicine 2000;7:273-82. View abstract.
Campbell MJ, Woodside JV, Honour JW, et al. Effect of red clover-derived isoflavone supplementation on insulin-like growth factor, lipid and antioxidant status in healthy female volunteers: a pilot study. Eur J Clin Nutr 2004;58(1):173-179. View abstract.
Cassady JM, Zennie TM, Chae YH, et al. Use of a mammalian cell culture benzo(a)pyrene metabolism assay for the detection of potential anticarcinogens from natural products: inhibition of metabolism by biochanin A, an isoflavone from Trifolium pratense L. Cancer Res 1988;48:6257-61. View abstract.
Chedraui P, San Miguel G, Hidalgo L, et al. Effect of Trifolium pratense-derived isoflavones on the lipid profile of postmenopausal women with increased body mass index. Gynecol Endocrinol 2008;24(11):620-624. View abstract.
Cheong JL, Bucknall R. Retinal vein thrombosis associated with a herbal phytoestrogen preparation in a susceptible patient. Postgrad Med J 2005;81:266-7.. View abstract.
Clifton-Bligh PB, Baber RJ, Fulcher GR, et al. The effect of isoflavones extracted from red clover (Rimostil) on lipid and bone metabolism. Menopause 2001;8:259-65. View abstract.
Clifton-Bligh PB, et al. Red cover isoflavones enriched with formononetin lower serum LDL cholesterol- a randomized, double-blind, placebo-controlled trial. Eur J Clin Nutr. 2015;69(1):134-142.
Coon JT, Pittler MH, Ernst E. Trifolium pratense isoflavones in the treatment of menopausal hot flushes: a systematic review and meta-analysis. Phytomedicine 2007;14(2-3):153-159. View abstract.
del Giorno C, Fonseca AM, Bagnoli VR, et al. Effects of Trifolium pratense on the climacteric and sexual symptoms in postmenopause women. Rev Assoc Med Bras 2010;56(5):558-562. View abstract.
Duncan AM, Underhill KE, Xu X, et al. Modest hormonal effects of soy isoflavones in postmenopausal women. J Clin Endocrinol Metab 1999;84:3479-84. View abstract.
Electronic Code of Federal Regulations. Title 21. Part 182 -- Substances Generally Recognized As Safe. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=182
Freeland-Graves JH, Lin PH. Plasma uptake of manganese as affected by oral loads of manganese, calcium, milk, phosphorus, copper, and zinc. J Am Coll Nutr 1991;10:38-43. View abstract.
Geller J, Sionit L, Partido C, et al. Genistein inhibits the growth of human-patient BPH and prostate cancer in histoculture. Prostate 1998;34:75-9. View abstract.
Geller SE, Shulman LP, van Breemen RB, et al. Safety and efficacy of black cohosh and red clover for the management of vasomotor symptoms: a randomized controlled trial. Menopause 2009;16:1156-66. View abstract.
Gerber G, Lowe FC, Spigelman S. The use of a standardized extract of red clover isoflavones for the alleviation of BPH symptoms. Endocrine Soc 82nd Ann Mtg, Toronto, CAN 2000;Jun 21-4:abstract 2359.
Ghazanfarpour M, et al. Red clover for treatment of hot flashes and menopausal symptoms: a systematic review and meta-analysis. J Obstet Gynaecol. 2015;36:301-311.
Ginsburg J, Prelevic GM. Lack of significant hormonal effects and controlled trials of phyto-oestrogens. Lancet 2000;355:163-4. View abstract.
Guerrero JA, Lozano ML, Castillo J, et al. Flavonoids inhibit platelet function through binding to the thromboxane A2 receptor. J Thromb Haemost 2005;3(2):369-376. View abstract.
Hale GE, Hughes CL, Robboy SJ, et al. A doubleblind randomized study on the effects of red clover isoflavones on the endometrium. Menopause 2001;8:338-46. View abstract.
Hargreaves DF, Potten CS, Harding C, et al. Two-week dietary soy supplementation has an estrogenic effect on normal premenopausal breast. J Clin Endocrinol Metab 1999;84:4017-24. View abstract.
Hidalgo LA, Chedraui PA, Morocho N, et al. The effect of red clover isoflavones on menopausal symptoms, lipids and vaginal cytology in menopausal women: a randomized, double-blind, placebo-controlled study. Gynecol Endocrinol 2005;21(5):257-264. View abstract.
Hodgson JM, Puddey IB, Beilin LJ, et al. Supplementation with isoflavonoid phytoestrogens does not alter serum lipid concentrations: a randomized controlled trial in humans. J Nutr 1998;128:728-32. View abstract.
Horn-Ross PL, John EM, Canchola AJ, et al. Phytoestrogen intake and endometrial cancer risk. J Natl Cancer Inst 2003;95:1158-64.. View abstract.
Howes J, Waring M, Huang L, Howes LG. Long-term pharmacokinetics of an extract of isoflavones from red clover (Trifolium pratense). J Altern Complement Med 2002;8:135-42. View abstract.
Howes JB, Bray K, Lorenz L, et al. The effects of dietary supplementation with isoflavones from red clover on cognitive function in postmenopausal women. Climacteric 2004;7(1):70-77. View abstract.
Howes JB, Sullivan D, Lai N, et al. The effects of dietary supplementation with isoflavones from red clover on the lipoprotein profiles of postmenopausal women with mild to moderate hypercholesterolemia. Atherosclerosis 2000;152:143-7. View abstract.
Howes JB, Tran D, Brillante D, Howes LG. Effects of dietary supplementation with isoflavones from red clover on ambulatory blood pressure and endothelial function in postmenopausal type 2 diabetes. Diabetes Obes Metab 2003;5(5):325-332. View abstract.
Imhof M, Gocan A, Reithmayr F, et al. Effects of a red clover extract (MF11RCE) on endometrium and sex hormones in postmenopausal women. Maturitas 2006;55(1):76-81. View abstract.
Ingram D, Sanders K, Kolybaba M, Lopez D. Case-control study of phyto-oestrogens and breast cancer. Lancet 1997;350-:990-4. View abstract.
Ingram DM, Hickling C, West L, et al. A double-blind randomized controlled trial of isoflavones in the treatment of cyclical mastalgia. The Breast 2002;11:170-4. View abstract.
Janssen K, Mensink RP, Cox FJ, et al. Effects of the flavonoids quercetin and apigenin on hemostasis in healthy volunteers: results from an in vitro and a dietary supplement study. Am J Clin Nutr 1998;67:255-62. View abstract.
Jarred RA, McPherson SJ, Jones ME, et al. Anti-androgenic action by red clover-derived dietary isoflavones reduces non-malignant prostate enlargement in aromatase knockout (ArKo) mice. Prostate 2003;56:54-64. View abstract.
Keinan-Boker L, van Der Schouw YT, Grobbee DE, Peters PH. Dietary phytoestrogens and breast cancer risk. Am J Clin Nutr 2004;79:282-8. View abstract.
Knight DC, Howes JB, Eden JA. The effect of Promensil, an isoflavone extract, on menopausal symptoms. Climacteric 1999;2:79-84.. View abstract.
Kondo K, Suzuki Y, Ikeda Y, Umemura K. Genistein, an isoflavone included in soy, inhibits thrombotic vessel occlusion in the mouse femoral artery and in vitro platelet aggregation. Eur J Pharmacol 2002;455(1):53-57. View abstract.
Krebs EE, Ensrud KE, MacDonald R, Wilt TJ. Phytoestrogens for treatment of menopausal symptoms: a systematic review. Obstet Gynecol 2004;104:824-36. View abstract.
Krieger D, Krieger S, Jansen O, et al. Manganese and chronic hepatic encephalopathy. Lancet 1995;346:270-4. View abstract.
Kurzer MS, Xu X. Dietary phytoestrogens. Annu Rev Nutr 1997;17:353-81. View abstract.
Le Bail JC, Champavier Y, Chulia AJ, Habrioux G. Effects of phytoestrogens on aromatase, 3beta and 17beta-hydroxysteroid dehydrogenase activities and human breast cancer cells. Life Sci 2000;66:1281-91. View abstract.
Lipovac M, Chedraui P, Gruenhut C, et al. Improvement of postmenopausal depressive and anxiety symptoms after treatment with isoflavones derived from red clover extracts. Maturitas 2010;65:258-61. View abstract.
Lissin LW, Cooke JP. Phytoestrogens and cardiovascular health. J Am Coll Cardiol 2000;35:1403-10. View abstract.
Liu J, Burdette JE, Xu H, et al. Evaluation of estrogenic activity of plant extracts for the potential treatment of menopausal symptoms. J Agric Food Chem 2001;49:2472-9.. View abstract.
Loing E, Lachance R, Ollier V, Hocquaux M. A new strategy to modulate alopecia using a combination of two specific and unique ingredients. J Cosmet Sci 2013;64(1):45-58. View abstract.
Maki PM, Rubin LH, Fornelli D, et al. Effects of botanicals and combined hormone therapy on cognition in postmenopausal women. Menopause 2009;16:1167-77. View abstract.
Moghissi KS. Risks and benefits of nutritional supplements during pregnancy. Obstet Gynecol 1981;58:68S-78S. View abstract.
Nelsen J, Barrette E, Tsouronix C, et al. Red clover (Trifolium pratense) monograph: A clinical decision support tool. J Herb Pharmacother 2002;2:49-72. View abstract.
Nelson HD, Vesco KK, Haney E, et al. Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis. JAMA 2006;295:2057-71. View abstract.
Nestel PJ, Pomeroy S, Kay S, et al. Isoflavones from red clover improve systemic arterial compliance but not plasma lipids in menopausal women. J Clin Endocrinol Metab 1999;84:895-8. View abstract.
O'Dell BL. Mineral interactions relevant to nutrient requirements. J Nutr 1989;119:1832-8. View abstract.
Orr A and Parker R. Red clover causing symptoms suggestive of methotrexate toxicity in a patient on high-dose methotrexate. Menopause Int. 2013;19(3):133-134.
Polini N, Rauschemberger MB, Mendiberri J, et al. Effect of genistein and raloxifene on vascular dependent platelet aggregation. Mol Cell Endocrinol 2007;267(1-2):55-62. View abstract.
Powles TJ, Howell A, Evans DG, et al. Red clover isoflavones are safe and well tolerated in women with a family history of breast cancer. Menopause Int 2008;14(1):6-12. View abstract.
Puschner B, Galey FD, Holstege DM, et al. Sweet clover poisoning in dairy cattle in California. J Am Vet Med Assoc 1998;212:857-9.. View abstract.
Risbridger GP, Wang H, Frydenberg M, Husband A. The in vivo effect of red clover diet on ventral prostate growth in adult male mice. Reprod Fertil Dev 2001;13:325-9. View abstract.
Risk assessment for peri- and post-menopausal women taking food supplements containing isolated isoflavones. EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS). 2015.
Roberts DW, Doerge DR, Churchwell MI, et al. Inhibition of extrahepatic human cytochromes P450 1A1 and 1B1 by metabolism of isoflavones found in Trifolium pratense (red clover). J Agric Food Chem 2004;52:6623-32. View abstract.
Rotem C, Kaplan B. Phyto-Female Complex for the relief of hot flushes, night sweats and quality of sleep: randomized, controlled, double-blind pilot study. Gynecol Endocrinol 2007;23:117-22. View abstract.
Samman S, Lyons Wall PM, Chan GS, et al. The effect of supplementation with isoflavones on plasma lipids and oxidisability of low density lipoprotein in premenopausal women. Atherosclerosis 1999;147(2):277-283. View abstract.
Schult TM, Ensrud KE, Blackwell T, et al. Effect of isoflavones on lipids and bone turnover markers in menopausal women. Maturitas 2004;48:209-18. View abstract.
Setchell KD, Cassidy A. Dietary isoflavones: biological effects and relevance to human health. J Nutr 1999;129:758S-67S. View abstract.
Setchell KD, Gosselin SJ, Welsh MB, et al. Dietary estrogens--a probable cause of infertility and liver disease in captive cheetahs. Gastroenterol 1987;93:225-33. View abstract.
Setchell KD. Absorption and metabolism of soy isoflavones-from food to dietary supplements and adults to infants. J Nutr 2000;130:654S-5S. View abstract.
Setchell KD. Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. Am J Clin Nutr 1998;68:1333S-46S. View abstract.
Simons LA, von Konigsmark M, Simons J, Celermajer DS. Phytoestrogens do not influence lipoprotein levels or endothelial function in healthy, postmenopausal women. Am J Cardiol 2000;85:1297-301. View abstract.
Simons LA, von Konigsmark M, Simons J, Celermajer DS. Phytoestrogens do not influence lipoprotein levels or endothelial function in healthy, postmenopausal women. Am J Cardiol 2000;85:1297-301. View abstract.
Taavoni S, Sahkeri F, Goshegir S, Haghani H. Effect of red clover on postmenopausal psychological symptoms, a triple blind randomized placebo control clinical trial [abstract].In: Abstracts of the 23rd European Congress of Psychiatry; 2015 March 28-31; Vienna, Austria. Eur Psychiatry 2015. Article nr 1829.
Terzic MM, Dotlic J, Maricic S, et al. Influence of red clover-derived isoflavones on serum lipid profile in postmenopausal women. J Obstet Gynaecol Res 2009;35(6):1091-1095. View abstract.
This P, De La Rochefordiere A, Clough K, et al. Phytoestrogens after breast cancer. Endocr Relat Cancer 2001;8:129-34. View abstract.
Tice J, Cummings SR, Ettinger B, et al. Few adverse effects of two red clover extracts rich in phytoestrogens: a multicenter, placebo-controlled trial. Alt Ther 2001;7:S33.
Tice JA, Ettinger B, Ensrud K, et al. Phytoestrogen supplements for the treatment of hot flashes: the Isoflavone Clover Extract (ICE) study: a randomized controlled trial. JAMA 2003;290:207-14.. View abstract.
Umland EM, Cauffield JS, Kirk JK, et al. Phytoestrogens as therapeutic alternatives to traditional hormone replacement in postmenopausal women. Pharmacotherapy 2000;20:981-90. View abstract.
Unger M, Frank A. Simultaneous determination of the inhibitory potency of herbal extracts on the activity of six major cytochrome P450 enzymes using liquid chromatography/mass spectrometry and automated online extraction. Rapid Commun Mass Spectrom 2004;18:2273-81. View abstract.
van de Weijer and Barentsen R. Isoflavones from red clover (Promensil®) significantly reduce hot flashes compared with placebo. Poster presented at: The North American Menopause Society's 12th Annual Meeting (2001).
van de Weijer P, Barentsen R. Isoflavones from red clover (Promensil) significantly reduce menopausal hot flush symptoms compared with placebo. Maturitas 2002;42:187-93. View abstract.
Villaseca P. Non-estrogen conventional and phytochemical treatments for vasomotor symptoms: what needs to be known for practice. Climacteric 2012;15(2):115-124. View abstract.
Vincent A, Fitzpatrick LA. Soy isoflavones: are they useful in menopause? Mayo Clin Proc 2000;75:1174-84. View abstract.
Weaver CM, Martin BR, Jackson GS, et al. Antiresorptive effects of phytoestrogen supplements compared with estradiol or risedronate in postmenopausal women using (41)Ca methodology. J Clin Endocrinol Metab 2009;94(10):3798-3805. View abstract.
Wuttke W, Jarry H, Seidlova-Wuttke D. Plant-derived alternative treatments for the aging male: facts and myths. Aging Male 2010;13(2):75-81. View abstract.
Yanagihara K, Ito A, Toge T, Numoto M. Antiproliferative effects of isoflavones on human cancer cell lines established from the gastrointestinal tract. Cancer Res 1993;53:5815-21. View abstract.
Zand RS, Jenkins DJ, Diamandis EP. Steroid hormone activity of flavonoids and related compounds. Breast Cancer Res Treat 2000;62:35-49. View abstract.
Zava DT, Dollbaum CM, Blen M. Estrogen and progestin bioactivity of foods, herbs, and spices. Proc Soc Exp Biol Med 1998;217:369-78. View abstract.